Wellington Management Group LLP Trims Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Wellington Management Group LLP lowered its stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 57.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 64,700 shares of the construction company's stock after selling 85,932 shares during the quarter. Wellington Management Group LLP owned about 0.08% of Aspen Aerogels worth $769,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Abbot Financial Management Inc. grew its stake in shares of Aspen Aerogels by 3.9% in the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company's stock valued at $359,000 after buying an additional 1,146 shares in the last quarter. Invesco Ltd. grew its position in Aspen Aerogels by 3.5% in the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock valued at $604,000 after acquiring an additional 1,724 shares in the last quarter. MetLife Investment Management LLC grew its position in Aspen Aerogels by 6.3% in the 4th quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company's stock valued at $425,000 after acquiring an additional 2,118 shares in the last quarter. Swiss National Bank increased its stake in Aspen Aerogels by 1.9% during the fourth quarter. Swiss National Bank now owns 128,800 shares of the construction company's stock worth $1,530,000 after purchasing an additional 2,400 shares during the period. Finally, Rhumbline Advisers lifted its position in shares of Aspen Aerogels by 2.8% during the fourth quarter. Rhumbline Advisers now owns 93,044 shares of the construction company's stock worth $1,105,000 after purchasing an additional 2,554 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Trading Up 4.3%

ASPN opened at $6.04 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $33.15. The company has a market cap of $495.91 million, a P/E ratio of 37.75 and a beta of 2.68. The business's 50-day simple moving average is $5.63 and its 200-day simple moving average is $9.02.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The firm had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. During the same period in the prior year, the company posted ($0.02) earnings per share. The firm's quarterly revenue was down 16.7% compared to the same quarter last year. As a group, equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insider Activity at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young acquired 20,000 shares of the stock in a transaction on Monday, May 12th. The shares were bought at an average cost of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer now owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This trade represents a 3.77% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 4.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on ASPN shares. Canaccord Genuity Group dropped their price objective on shares of Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 14th. Barclays reaffirmed an "equal weight" rating and set a $7.00 price objective (down previously from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th. B. Riley decreased their target price on Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating for the company in a report on Wednesday, February 19th. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. Finally, Wall Street Zen raised Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $18.44.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.